Sun Yat-sen University: Lymphoma, Extranodal NK-T-Cell trials

The registry lists 10 Lymphoma, Extranodal NK-T-Cell studies with Sun Yat-sen University as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 7Phase 3 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell LymphomaNot yet recruitingNCT07542912Not applicable
• Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTLRecruitingNCT06406556Phase 2
• Prognostic Nomogram of Extranodal NK/T-cell LymphomaRecruitingNCT04554511
• Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTLStatus unknownNCT04676789Phase 2
• P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma PatiensTerminatedNCT02533323Phase 2
• Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early StageTerminatedNCT02359162Phase 3
• Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX ChemotherapyStatus unknownNCT02229682Phase 2
• Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTLStatus unknownNCT02080234Phase 2
• GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell LymphomaStatus unknownNCT01991158Phase 2
• Avastin+ GemAOD As First-Line Treatment in NK/T Cell LymphomaStatus unknownNCT01921790Phase 2